SMAD3 and breast carcinoma: The interaction between ZNF8 and Smad3 was confirmed in MDA‐MB‐231, MCF‐7, and T47D breast cancer cells by co‐immunoprecipitation (Co‐IP), which also showed that the interaction was enhanced after TGF‐β pathway activation (Figure 1G,H).